---

Related Articles:

Inhibitory effect of ramosetron on corticotropin releasing factor- and soybean oil-induced delays in gastric emptying in rats.

2012-09-01

[J. Gastroenterol. Hepatol. 27(9) , 1505-11, (2012)]

Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine.

2011-12-01

[Neurogastroenterol. Motil. 23(12) , 1098-104, (2011)]

Treatment of IBS-D with 5-HT3 receptor antagonists vs spasmolytic agents: similar therapeutical effects from heterogeneous pharmacological targets.

2011-12-01

[Neurogastroenterol. Motil. 23(12) , 1051-5, (2011)]

Comparison of the efficacy of ramosetron and ondansetron in the prophylaxis of postoperative vomiting in children receiving fentanyl by patient-controlled analgesia after orthopedic surgery: a randomized controlled trial.

2013-04-01

[Paediatr. Anaesth. 23(4) , 360-4, (2013)]

Reevaluation of the effectiveness of ramosetron for preventing postoperative nausea and vomiting: a systematic review and meta-analysis.

2013-08-01

[Anesth. Analg. 117(2) , 329-39, (2013)]